With an average of seven years to pinpoint a diagnosis, with less than 250 FDA approved treatments, patients with one of the over 7,000 different rare diseases are currently facing some of the highest unmet medical needs.

Multiomics Represents the Subsets of Omics – Genomics, Transcriptomics, Proteomics, Metabolomics and Phenomics

With a complete clinical picture via multiomic data, the process and precision of treating rare diseases is being redefined. We are able to gain multilayer insights to provide the most accurate diagnosis, develop better disease models, and thus deliver more precise medicine.

A multiomic approach constitutes a unique and highly effective tool for the early diagnosis of rare, metabolic, and neurodegenerative diseases

Biochemical testing allows for orthogonal confirmation of disease – accelerating the path to a diagnosis by avoiding stepwise testing

Integrated genomic and biochemical testing facilitates the decision on the pathogenicity of clinical variants leading to higher diagnostic yield

Multiomics provides a complete clinical picture – enabling the assessment of disease severity and thus accelerating personalized treatments

Case Studies

A genetic test alone may not be able to provide the information needed for a final diagnosis.

CENTOGENE a man carries a boy in his arms

Leveraging a Multiomic Approach to Establish a Genetic Diagnosis with CentoMetabolic MOx

Read our Gaucher Case Study

Applying a Multiomic Approach to Diagnose and Treat a Young Rare Disease Patient

Read our GLB1 Case Study

Explore the Next Generation of Whole Exome Sequencing

Read our CentoXome MOx Case Study

Explore the Next Generation of Whole Genome Sequencing

Read our CentoGenome MOx Case Study

You not only helped on this occasion, but you and your colleagues help every single day, on every occasion.

Dr. Willie Reardon, Ireland

We Have Pioneered a Combination of Different Omics With an Optimized Testing Strategy

Metabolic Testing MOx

~200 genes associated with >180 Inherited Metabolic Disorders

Explore CentoMetabolic MOx

WES MOx

~20,000 genes, with focus on the exome
>7,000 rare diseases, including >1,400 Inherited Metabolic Disorders

Explore CentoXome MOx

CENTOGENE Little Child Looking out of Window With Binoculars

WGS MOx

>20,000 genes, entire genome
>7,000 rare diseases, including >1,400 Inherited Metabolic Disorders

Explore CentoGenome MOx

A diagnosis that covers the depth and breadth of a patient’s biology – allowing you to truly understand the cause of a disease – is fundamental.

In continuously bringing advanced multiomic diagnostic products to market, we are building unparalleled insights and the know-how to find therapeutic approaches faster and positively impact patients' lives.

With an average of seven years to pinpoint a diagnosis, with less than 250 FDA approved treatments, patients with one of the over 7,000 different rare diseases are currently facing some of the highest unmet medical needs.

Explore the Next Generation of Whole Exome Sequencing

Explore the Next Generation of Whole Genome Sequencing

We Have Pioneered a Combination of Different Omics With an Optimized Testing Strategy

Metabolic Testing MOx

WES MOx

WGS MOx

A diagnosis that covers the depth and breadth of a patient’s biology – allowing you to truly understand the cause of a disease – is fundamental.

Related Articles & Webinars

An Encyclopedia for Mass Spectrometry Lipidomics

A Multiomic Approach to Diagnosing Patients and Accelerating Treatments

Broader Applicability of Rare Disease Biomarker

Enzymes and Biomarkers Included in MOx Products